Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma.

The Journal of international medical research - 1 Jul 2024

Min Bo, Wang Yan

Abstract excerpt

OBJECTIVE: The prognosis of lung adenocarcinoma (LUAD), which is the most common type of lung cancer, remains poor. Little is known about the function and mechanism of whey acidic protein four-disulfide core domain 2 (WFDC2) in LUAD. METHODS: In this study, we used online databases to compare WFDC2 expression between LUAD and normal tissues, to analyze the relationship between WFDC2 and overall survival, and to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Immunotherapy

Share to Lung Neoplasms

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 39068532
DOI: 10.1177/03000605241258893
PMCID: PMC11287736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma.PMID 39068532Read ↗

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genesSemantic proximity Read ↗

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinomaSemantic proximity Read ↗

Identification of the disulfidptosis-related key gene CD2AP as a potential biomarker and new therapeutic target for LUAD patients by comprehensive multi-omics analysisSemantic proximity Read ↗

DOCK2 is a Biomarker for Predicting the Prognosis of Lung Adenocarcinoma and Associated with Immune InfiltrationSemantic proximity Read ↗

Comprehensive Analysis of KPNA2 as a Prognostic Biomarker in Lung Adenocarcinoma: Associations with Ferroptosis and Immune InfiltrationSemantic proximity Read ↗

TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of prognosis and tumor immune microenvironment of cuproptosis-related gene CDKN2A in lung adenocarcinomaSemantic proximity Read ↗

Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and Indicator of Tumor Immune Cell Infiltration in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensively analysis of the FGD family with potential effects on prognosis and immune infiltration in lung adenocarcinomaSemantic proximity Read ↗

Evaluation of Clinical Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma via BioinformaticsSemantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.